✦ LIBER ✦

446 PUBLICATION A phase II trial of trastuzumab (H) plus capecitabine (X) as first-line treatment in patients (pts) with HER-2-positive metastatic breast cancer (MBC)

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2124 POSTER Triple combination of oral v

✍ A. Chan; V. Ganju; D. Becquart; P.F. Conte; L. Petruzelka; O. Perrot; G. Villano 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Trastuzumab (Herceptin®) plus docetaxel

✍ J.M Extra; F Cognetti; D Maranichi; R Snyder; L Mauriac; M Tubiana-Hulin; S Chan 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 348 KB

194 A Phase II Study of Trastuzumab Plus

✍ A. Urruticoechea; P. Canney; R. Separovic; T. Bachelot; J. Efran; J.L. Canon; P. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

First-line trastuzumab (H), oral vinorel

✍ A. Chan; V. Ganju; D. Becquart; P.F. Conte; L. Petruzelka; L. Goedhals; M. Gil G 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Trastuzumab plus docetaxel with or witho

✍ A. Wardlev; A. Anton-Torres; X. Pivot; F. Morales-Vasquez; L. Zetina; M. de Fati 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Phase II Trial of Weekly Docetaxel, Vino

✍ Jeffrey R. Infante; Denise A. Yardley; Howard A. Burris III; F. Anthony Greco; C 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 120 KB